Literature DB >> 9527060

Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.

A Schott1, I Vogel, U Krueger, H Kalthoff, H W Schreiber, W Schmiegel, D Henne-Bruns, B Kremer, H Juhl.   

Abstract

OBJECTIVE: To evaluate the prognostic significance of isolated tumor cells detected by a panel of various monoclonal antibodies. SUMMARY BACKGROUND DATA: Previously, we showed by using immunocytology that cancer cells are frequently found in bone marrow and peritoneal cavity samples of gastrointestinal cancer patients.
METHODS: Findings in bone marrow and peritoneal cavity samples were compared and correlated with the 4-year survival rate of 84 gastric and 109 colorectal patients with cancer.
RESULTS: Although positive results in the bone marrow showed little prognostic significance, the peritoneal cavity results correlated with the 4-year survival rate (gastric cancer: p = 0.0038; colorectal cancer: p = 0.0079). Additionally, in subgroups of patients with early (gastric cancer: p = 0.02, colorectal cancer: p = 0.48) and advanced (gastric cancer: p = 0.02, colorectal cancer: p < 0.0001) tumor stages, a correlation of immunocytologic findings and the survival rate was seen.
CONCLUSIONS: The detection of minimal residual disease in the peritoneal cavity serves as a new prognostic marker.

Entities:  

Mesh:

Year:  1998        PMID: 9527060      PMCID: PMC1191275          DOI: 10.1097/00000658-199803000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

Authors:  G Schlimok; I Funke; B Holzmann; G Göttlinger; G Schmidt; H Häuser; S Swierkot; H H Warnecke; B Schneider; H Koprowski; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  [Differential cytology of effusions using monoclonal antibodies].

Authors:  J Lüttges; K Neumann; K H Pflüger; P Schmitz-Moormann
Journal:  Pathologe       Date:  1988-05       Impact factor: 1.011

3.  Antigenic sites in carcinoembryonic antigen.

Authors:  S Hammarstrom; J E Shively; R J Paxton; B G Beatty; A Larsson; R Ghosh; O Bormer; F Buchegger; J P Mach; P Burtin
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

4.  Prognostic and therapeutic values of peritoneal cytology in gastric cancer.

Authors:  T Nakajima; S Harashima; M Hirata; T Kajitani
Journal:  Acta Cytol       Date:  1978 Jul-Aug       Impact factor: 2.319

5.  Colorectal carcinoma antigens detected by hybridoma antibodies.

Authors:  H Koprowski; Z Steplewski; K Mitchell; M Herlyn; D Herlyn; P Fuhrer
Journal:  Somatic Cell Genet       Date:  1979-11

Review 6.  Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.

Authors:  R Jung; P Ahmad-Nejad; M Wimmer; M Gerhard; C Wagener; M Neumaier
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-01

7.  Detection of micrometastases in patients with primary breast cancer.

Authors:  W H Redding; R C Coombes; P Monaghan; H M Clink; S F Imrie; D P Dearnaley; M G Ormerod; J P Sloane; J C Gazet; T J Powles
Journal:  Lancet       Date:  1983-12-03       Impact factor: 79.321

8.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

9.  Monoclonal antibody-defined human pancreatic cancer-associated antigens.

Authors:  W H Schmiegel; H Kalthoff; R Arndt; J Gieseking; H Greten; G Klöppel; C Kreiker; A Ladak; V Lampe; S Ulrich
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

10.  Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.

Authors:  V Combaret; M C Favrot; B Kremens; I Philip; C Bailly; B Fontaniere; O Gentilhomme; F Chauvin; J M Zucker; J L Bernard
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  34 in total

1.  Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Authors:  Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio Cesare Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter Richard Marti
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

2.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

Review 3.  Biology and significance of circulating and disseminated tumour cells in colorectal cancer.

Authors:  Gunnar Steinert; Sebastian Schölch; Moritz Koch; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2012-02-15       Impact factor: 3.445

Review 4.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

Review 5.  Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  César P Ramírez Plaza; Manuel A Cobo Dols; Alberto Gómez Portilla; Agustín de la Fuente Perucho
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

6.  Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: is it useful?

Authors:  E J Nieveen van Dijkum; P D Sturm; L T de Wit; J Offerhaus; H Obertop; D J Gouma
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

Review 7.  Detection and clinical implications of minimal residual disease in gastro-intestinal cancer.

Authors:  Fabian Wolfrum; Ilka Vogel; Fred Fändrich; Holger Kalthoff
Journal:  Langenbecks Arch Surg       Date:  2005-07-01       Impact factor: 3.445

8.  Impact of positive intraabdominal lavage cytology on the long-term prognosis of colorectal cancer patients.

Authors:  Rita Temesi; László Sikorszki; János Bezsilla; Akos Botos; Judit Kovács; Tibor Tihanyi
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

9.  Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice.

Authors:  Patrick Favoulet; Laurent Benoit; Liliana Osmak; Emmanuel Polycarpe; Philippe Esquis; Christian Duvillard; Boris Guiu; Patrick Rat; Jean Pierre Favre; Bruno Chauffert
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

10.  The inhibition of tumor cell adhesion on human mesothelial cells (HOMC) by phospholipids in vitro.

Authors:  M Jansen; P Lynen Jansen; J Otto; T Kirtil; S Neuss; K-H Treutner; V Schumpelick
Journal:  Langenbecks Arch Surg       Date:  2006-03-14       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.